Arca
Skip to content
Tools
Tools

Pregabalin Capsules 50mg

Recall D-0541-2024, part of FDA recall event 94642. See Rising Pharma Holdings's company page.

Rising Pharma Holding, Inc. started this Class III drug recall on May 16, 2024 (voluntary: firm initiated); FDA lists it as ongoing.

  • Classification: Class III
  • Started: May 16, 2024
  • Status: Ongoing

Why It Was Recalled

Class III

Presence of Foreign Tablets/Capsules: Complaint received from a re-packager, American Health Packaging (AHP), where a foreign tablet was discovered in one of the bottles during packaging set up. Tablet identified as pantoprazole tablet 20mg.

Record

Product
Pregabalin Capsules 50mg, 1000-count bottle, Rx Only, Manufactured for: Rising Pharma Holdings, Inc., East Brunswick, NJ 08816, Manufactured by: Laurus Labs Limited, Anakapalli-531011, India, NDC 64980-411-10
Quantity
N/A
Lots and codes
Lot: 23132611, Exp 07/31/2026
Distribution
Nationwide in the USA
Recalling firm
Rising Pharma Holding, Inc., East Brunswick, NJ, United States
How the firm notified
N/A
FDA classified
Jun 4, 2024

Rising Pharma Holding, Inc.'s Other Recalls

Newest first, one product per recall event; search them all

FDA's weekly Enforcement Report, as openFDA publishes it. A recall is classified by how likely the product is to cause harm: Class I is the most serious. openFDA drug enforcement reports

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.